Company · CIK 1314026
Aspreva Pharmaceuticals CORP
| CIK | 1314026 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | A1 |
| Business address | British Columbia, Canada |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2005-05-13 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-122234 | 2005-01-24 | 2005-03-04 | 6 |
Filings
6| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2005-03-04 | 424B4Final prospectus | 333-122234 | 0000945234-05-000141 |
| 2005-03-01 | F-1/AAmendment | 333-122234 | 0000945234-05-000114 |
| 2005-02-28 | F-1/AAmendment | 333-122234 | 0000945234-05-000106 |
| 2005-02-15 | F-1/AAmendment | 333-122234 | 0000945234-05-000087 |
| 2005-02-11 | F-1/AAmendment | 333-122234 | 0000945234-05-000071 |
| 2005-01-24 | F-1Registration filed | 333-122234 | 0000945234-05-000025 |